Eficacia de la vacuna viva IBR

Inicio Conocimiento Eficacia de la vacuna viva IBR

Eficacia de la vacuna viva IBR

IBR (Infectious Bovine Rhinotracheitis) eradication programs in the EU are based mainly on a DIVA (Differentiation of Infected from Vaccinated Animals) strategy by using marker vaccines. So far, all these IBR marker vaccines were based on single deleted BoHV-1 gE- strains: Bovine HerpesVirus-1 strains lacking glycoprotein E.

Sobre este artículo

Autores

Moreno, A.; Casado, C.; Roca, M.; Creixans, O.

Resumen

The attenuated MLV IBR vaccine with a double genetic deletion gE-tk- (HIPRABOVIS® IBR Marker Live, HIPRA) proved to be effective, fulfilling the requirements of the monograph of the European Pharmacopeia for live vaccines against IBR.

Compartir en